← Evidence map

ArticleBioactive materials2023

HDAC I/IIb selective inhibitor Purinostat Mesylate combined with GLS1 inhibition effectively eliminates CML stem cells.

Qiang Qiu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

9 papers cite it

2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 36185739